How Clinics Choose a Peptide Supplier: A Due-Diligence Checklist

Short answer: Choosing a peptide supplier for a clinic comes down to five verifiable items: the manufacturer's GMP certification tier, whether real certificates of analysis exist for every SKU you'd stock, whether the supplier discloses its own gaps, whether the regulatory trajectory of the compounds is tracked, and whether you can independently verify a sample before committing.

This checklist is written for clinic buyers — wellness clinics, med spas, PT practices — evaluating any peptide supplier, including us. For the broader category overview, start with our wholesale peptides pillar; for the consumer-side version of this scrutiny, see peptide sourcing red flags.

1. What GMP tier does the manufacturer actually hold?

"GMP" is not one thing. The question to ask is: certified to which standard, by whom, and when?

A worked example from our own supply chain, gaps included: InstaMed does not disclose who makes its strips, and the only documented thread we hold is that one lot COA is printed on Nutrastrips (Draper, UT) letterhead. Nutrastrips itself holds NSF/ANSI 455-2 GMP certification, dated August 2024, and operates as an FDA-registered food facility under 21 CFR 111/117 [documented — research dossier] — but a letterhead on one lot is not a disclosed manufacturing relationship, which is exactly the kind of gap this question is meant to surface. That is also a dietary-supplement GMP standard. It is not drug GMP, and it is not a 503A/503B compounding standard — an important distinction, because no supplement-certified facility confers drug status on anything it produces.

So the checklist question for any supplier: which certification body, which standard, what date — and does the certificate cover the actual facility making your product, or a different site in the same company?

2. Do COAs exist — for every SKU — and can you actually read them?

A certificate of analysis is only useful if it exists, is current, and is legible. Ask for the COA for each specific SKU and lot you'd stock, not a sample COA for the flagship product.

We'll hold ourselves to this standard. In our own catalog documentation, COAs exist for seven SKUs but five SKUs — SLEEP, BOOST, KLOW, NEURO, and ULTRATRUTIDE — have no COA at all [documented — PRODUCT-DATA]. Two more quirks worth knowing because they're the kind of thing to check anywhere: one SKU's COA has no potency table (it goes from appearance to heavy metals and microbials without a per-strip assay result), and another is on the manufacturer's letterhead rather than the brand's template, meaning more than one lab is involved. On the official storefronts, COAs appear as embedded product-gallery images rather than downloadable documents [documented — catalog recon].

A supplier that publishes its COA gaps is demonstrating something a supplier with a polished claims page is not. Our guide on how to read a peptide COA covers what a complete one should contain.

3. Is the product category legal for what you plan to do with it?

"Research-use-only" houses are categorically unsuitable for clinic resale [documented — research dossier]. A vial labeled "not for human use" cannot be retailed to clients no matter how clean the COA looks — the label is a liability device for the seller, not a quality grade for you.

Also track the regulatory trajectory of the compounds themselves. In July 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend several peptides — including BPC-157, KPV, TB-500 (8–6) and MOTS-c (7–5) — for the 503A Bulks List, with DSIP rejected; any resulting rulemaking is realistically a mid-to-late 2027 event [documented — research dossier]. That's advisory, not binding — but a supplier who can't discuss it hasn't done their own homework. The compliance-side questions belong with your counsel; our clinic compliance overview maps the territory.

4. Can you verify a sample independently?

"Trust but verify" is cheap in this category. Independent labs will run single-peptide identity/potency testing — Janoshik, for example, runs roughly $85–$130 for a single-peptide HPLC + LC-MS panel, with blends at higher prices and turnaround measured in days to a few weeks [documented — research dossier]. If a supplier objects to you testing a sample, that's your answer.

5. Does the supplier say what it doesn't know?

This is the softest item and, in our view, the most predictive. Does the supplier distinguish its verified facts from its marketing language? Does it tell you which SKUs lack testing? Does it separate "studied in animals" from "proven in humans" when describing its compounds?

A note on us, in the same spirit: InstaMed's bioavailability and IP language ("delivery technology," "pending patents") is brand claim — public records show trademark applications, not issued patents — and we tag it as unverified wherever it appears on this site. Any supplier you evaluate should be able to survive the same sentence-by-sentence scrutiny.

What this checklist can't do

Honesty passage: a checklist reduces risk; it does not certify outcomes. A supplier can pass every item above and still ship a bad lot — which is why item 4 (independent verification) is the one we'd least want to skip. And no checklist substitutes for legal advice on scope-of-practice, resale eligibility in your state, or what your professional license permits you to retail. Those questions go to your attorney and your board, not to a blog post — ours or anyone's.

The bottom line

Choose suppliers the way you'd want your clients to choose you: on documents, not adjectives. Certification tier with a date, COAs per SKU with the gaps admitted, a legal product category, independent testability, and a habit of self-disclosure. If you'd like to see how our program handles those questions, the wholesale application is the place to start — pricing there is login-gated, and the documents above are exactly what we'd suggest you request first.

For a worked example of what that documentation looks like on a live listing, the BPC-157 strips page publishes the panel, the lot and the COA together.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.